|
1
|
Lee DY, Fletcher E, Martinez O, et al:
Vascular and degenerative processes differentially affect regional
interhemispheric connections in normal aging, mild cognitive
impairment, and Alzheimer disease. Stroke. 41:1791–797. 2010.
View Article : Google Scholar
|
|
2
|
Aluise CD, Robinson RA, Beckett TL, et al:
Preclinical Alzheimer disease: brain oxidative stress, Abeta
peptide and proteomics. Neurobiol Dis. 39:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou ZD, Chan CH, Ma QH, Xu XH, Xiao ZC
and Tan EK: The roles of amyloid precursor protein (APP) in
neurogenesis: implications to pathogenesis and therapy of Alzheimer
disease. Cell Adh Migr. 5:280–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Armstrong J, Boada M, Rey MJ, Vidal N and
Ferrer I: Familial Alzheimer disease associated with A713T mutation
in APP. Neurosci Lett. 370:241–243. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esh C, Patton L, Kalback W, et al: Altered
APP processing in PDAPP (Val717→Phe) transgenic mice yields
extended-length Abeta peptides. Biochemistry. 44:13807–13819.
2005.PubMed/NCBI
|
|
6
|
Ceballos-Picot I, Nicole A and Sinet PM:
Cellular clones and transgenic mice overexpressing copper-zinc
superoxide dismutase: models for the study of free radical
metabolism and aging. EXS. 62:89–98. 1992.PubMed/NCBI
|
|
7
|
Moon EY, Oh JM, Kim YH, Ryoo IJ and Yoo
ID: Clitocybins, novel isoindolinone free radical scavengers, from
mushroom Clitocybe aurantiaca inhibit apoptotic cell death
and cellular senescence. Biol Pharm Bull. 32:1689–1694. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Percy ME, Dalton AJ, Markovic VD, et al:
Red cell superoxide dismutase, glutathione peroxidase and catalase
in Down syndrome patients with and without manifestations of
Alzheimer disease. Am J Med Genet. 35:459–467. 1990. View Article : Google Scholar
|
|
9
|
Loewenstein DA, Acevedo A, Czaja SJ and
Duara R: Cognitive rehabilitation of mildly impaired Alzheimer
disease patients on cholinesterase inhibitors. Am J Geriatr
Psychiatry. 12:395–402. 2004. View Article : Google Scholar
|
|
10
|
Lamirault L, Guillou C, Thal C and Simon
H: (-)-9-Dehydrogalanthaminium bromide, a new cholinesterase
inhibitor, enhances place and object recognition memory in young
and old rats. Neurobiol Learn Mem. 80:113–122. 2003. View Article : Google Scholar
|
|
11
|
Gibb WR, Mountjoy CQ, Mann DM and Lees AJ:
Pathological study of the association between Lewy body disease and
Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 52:701–708.
1989.
|
|
12
|
Tohgi H, Abe T, Hashiguchi K, Saheki M and
Takahashi S: Remarkable reduction in acetylcholine concentration in
the cerebrospinal fluid from patients with Alzheimer type dementia.
Neurosci Lett. 177:139–142. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Wang G, Liu J, et al: Puerarin
attenuates amyloid-beta-induced cognitive impairment through
suppression of apoptosis in rat hippocampus in vivo. Eur J
Pharmacol. 649:195–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim JW, Lee DY, Choo IH, et al:
Microstructural alteration of the anterior cingulum is associated
with apathy in Alzheimer disease. Am J Geriatr Psychiatry.
19:644–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saber AJ and Cain DP: Combined
beta-adrenergic and cholinergic antagonism produces behavioral and
cognitive impairments in the water maze: implications for Alzheimer
disease and pharmacotherapy with beta-adrenergic antagonists.
Neuropsychopharmacology. 28:1247–1256. 2003. View Article : Google Scholar
|
|
16
|
Wang L, Khan A, Csernansky JG, et al:
Fully-automated, multi-stage hippocampus mapping in very mild
Alzheimer disease. Hippocampus. 19:541–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Polidori MC and Mecocci P: Plasma
susceptibility to free radical-induced antioxidant consumption and
lipid peroxidation is increased in very old subjects with Alzheimer
disease. J Alzheimers Dis. 4:517–522. 2002.PubMed/NCBI
|
|
18
|
Moreira PI, Sayre LM, Zhu X, Nunomura A,
Smith MA and Perry G: Detection and localization of markers of
oxidative stress by in situ methods: application in the study of
Alzheimer disease. Methods Mol Biol. 610:419–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aksenov MY, Tucker HM, Nair P, et al: The
expression of key oxidative stress-handling genes in different
brain regions in Alzheimer’s disease. J Mol Neurosci. 11:151–164.
1998.PubMed/NCBI
|
|
20
|
Evereklioglu C, Er H, Doganay S, et al:
Nitric oxide and lipid peroxidation are increased and associated
with decreased antioxidant enzyme activities in patients with
age-related macular degeneration. Doc Ophthalmol. 106:129–136.
2003. View Article : Google Scholar
|
|
21
|
Bales KR, Tzavara ET, Wu S, et al:
Cholinergic dysfunction in a mouse model of Alzheimer disease is
reversed by an anti-A beta antibody. J Clin Invest. 116:825–832.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao F, Li XG, Zhang XY, et al: Combined
administration of D-galactose and aluminium induces Alzheimer-like
lesions in brain. Neurosci Bull. 27:143–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lestaevel P, Bensoussan H, Racine R,
Airault F, Gourmelon P and Souidi M: Transcriptomic effects of
depleted uranium on acetylcholine and cholesterol metabolisms in
Alzheimer’s disease model. C R Biol. 334:85–90. 2011.PubMed/NCBI
|
|
24
|
Sultana R, Robinson RA, Di Domenico F, et
al: Proteomic identification of specifically carbonylated brain
proteins in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human
double mutant knock-in mice model of Alzheimer disease as a
function of age. J Proteomics. 74:2430–2440. 2011. View Article : Google Scholar
|
|
25
|
Monji A, Utsumi H, Ueda T, et al:
Amyloid-beta-protein (A beta) (25–35)-associated free radical
generation is strongly influenced by the aggregational state of the
peptides. Life Sci. 70:833–841. 2002.
|
|
26
|
Tamaoka A, Fraser PE, Ishii K, et al:
Amyloid-beta-protein isoforms in brain of subjects with PS1-linked,
beta APP-linked and sporadic Alzheimer disease. Brain Res Mol Brain
Res. 56:178–185. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeong SJ, Kim K and Suh YH: Age-related
changes in the expression of Alzheimer’s beta APP in the brain of
senescence accelerated mouse (SAM)-P/10. Neuroreport. 8:1733–1737.
1997.
|
|
28
|
Mishra S and Caflisch A: Dynamics in the
active site of β-secretase: a network analysis of atomistic
simulations. Biochemistry. 50:9328–9339. 2011.
|
|
29
|
Singer O, Marr RA, Rockenstein E, et al:
Targeting BACE1 with siRNAs ameliorates Alzheimer disease
neuropathology in a transgenic model. Nat Neurosci. 8:1343–1349.
2005. View
Article : Google Scholar : PubMed/NCBI
|
